Claudio Llaurado, BS

Pilot Study of Oral Rapamycin to Prevent Restenosis in Patients Undergoing Coronary Stent Therapy: Argentina Single-Center Study

08/01/2008

Miguel Russo , MD;

John A. Ambrose , MD;

Claudio Llaurado , BS;

Carlos Fernandez-Pereira , MD;

Alfredo E. Rodriguez , MD, PhD;

Renu Virmani , MD, PhD;

Maximo Rodriguez Alemparte , MD;

Cesar F. Vigo , MD;

Observational and randomized studies recently showed that sirolimus-coated stents were associated with a lower rate of restenosis than bare stents.1–3 Although the restenosis rate was lower, coated stents have a significantly higher cost than...

Observational and randomized...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

New Coating Stent Design for Patients with High-Risk Coronary Lesions for Thrombotic Events: (Full title below)

08/17/2009

Gilberto Perez , MD;

Alfredo M. Rodriguez-Granillo , BS;

Juan Mieres , MD;

Claudio Llaurado , BS;

Bibiana Rubilar , MD;

Gustavo Risau , MD;

Carlos Fernandez-Pereira , MD;

Alfredo E. Rodriguez , MD, PhD;

ABSTRACT: Background. Semisynthetic coating of the Camouflage bare-metal stent (BMS) (Eucatech AG, Rheinfelden, Germany) mimics luminal endothelial cell glycocalix, potentially preventing the activation of the coagulation system. Purpose. We...

ABSTRACT: Background....

08/17/2009

Journal of Invasive Cardiology